HDBuzz
banner
hdbuzzfeed.bsky.social
HDBuzz
@hdbuzzfeed.bsky.social
Huntington’s disease research news. In plain language. Written by scientists. hdbuzz.net
Editors - @sjh508 @rjharding
Unique research highlights an overlooked mental health disparity among Indigenous North American people with Huntington’s disease (HD) - and the need for care grounded in trust, community partnership, and cultural understanding.

Read more here: en.hdbuzz.net/highlighting...
September 21, 2026 at 1:10 PM
Skyhawk Therapeutics shared data for SKY-0515, an experimental once-daily pill that targets both huntingtin and somatic instability, making it a possible “two-for-one” drug to treat HD.

Read more about this exciting news on HDBuzz → en.hdbuzz.net/encouraging-...
September 16, 2026 at 1:00 PM
What if nutrition is one of the warning lights we should be checking earlier in Huntington’s disease? New research suggests simple nutrition measures may help identify when people with HD need extra support.

en.hdbuzz.net/food-for-tho...
September 14, 2026 at 1:01 PM
A review of 23 studies suggests that EEG could offer a non-invasive way to track brain changes across the course of Huntington’s disease (HD). #hdresearch

Read all about it → en.hdbuzz.net/could-brain-...
September 10, 2026 at 1:01 PM
Five Huntington’s disease (HD) researchers discuss the cutting-edge techniques driving their work, accelerating discovery and guiding development of treatments. #hdresearch

Read all about it → en.hdbuzz.net/hot-techniqu...
September 7, 2026 at 1:08 PM
What if Huntington’s disease (HD) changes how we “see” the world before we even notice symptoms? New research suggests visual thinking skills may help track HD progression.

en.hdbuzz.net/keeping-an-e...
September 3, 2026 at 1:05 PM
NEWS! uniQure has submitted AMT-130 for regulatory approval in the US and UK. This drug is NOT yet approved; regulators must now review the evidence. Read more about this milestone here -> uniqure.gcs-web.com/node/12991/pdf and on HDBuzz here -> en.hdbuzz.net/the-other-sh...
September 2, 2026 at 10:40 PM
August was a busy month for Huntington’s disease (HD) research! Setbacks, new trials, a conference, and the HDBuzz Prize for Young Science Writers!

Catch up on everything in our monthly roundup: en.hdbuzz.net/august-2026-...
August 31, 2026 at 1:03 PM
A new Huntington's disease (HD) clinical trial has officially begun! It will test whether the drug pridopidine can slow the progression of HD.

For more details, read our article: en.hdbuzz.net/first-partic...
August 27, 2026 at 1:00 PM
Reposted by HDBuzz
Rachel Harding & Leora Fox from @hdbuzzfeed.bsky.social will join us on 9/9 to share the buzz from HDF’s recent HD2026 Symposium. They'll recap some of the exciting science from the meeting and hold a live Q&A.
Register Now: us06web.zoom.us/.../501.../W...
#curehd #HD2026 #researchspotlightwebinars
August 25, 2026 at 2:26 PM
Reposted by HDBuzz
If you've got stage 2 HD and want to do a science, here's a new Phase 1 study for a potential injectable therapy. They've got a cunning plan for getting treatments across the blood-brain barrier.
New Huntington’s disease (HD) trial begins! A Phase 1 study is testing SRP-1005, a huntingtin-lowering therapy given by injection under the skin. It’s early days, but this approach could add an important new arrow to the HD drug development quiver.

More details here -> en.hdbuzz.net/a-shot-in-th...
August 20, 2026 at 1:25 PM
New research points to HTT1a, a toxic shortened form of huntingtin (HTT), as a key driver of disease and a promising therapeutic target in Huntington’s disease (HD).

Read the full article here: en.hdbuzz.net/taking-a-sho...
August 24, 2026 at 1:11 PM
New Huntington’s disease (HD) trial begins! A Phase 1 study is testing SRP-1005, a huntingtin-lowering therapy given by injection under the skin. It’s early days, but this approach could add an important new arrow to the HD drug development quiver.

More details here -> en.hdbuzz.net/a-shot-in-th...
August 20, 2026 at 1:00 PM
Reposted by HDBuzz
Thanks, Leora Fox & Rachel Harding @hdbuzzfeed.bsky.social, for the excellent summary of my presentation at @hdfcures.bsky.social Meeting on the #HUNTIAM clinical trial (Thiamine+Biotin) for HD, including the evidence that originated it.
👇👇👇
en.hdbuzz.net/hd2026-milto...
@cbm-csic-uam.bsky.social
Thank you – HDBuzz
en.hdbuzz.net
August 20, 2026 at 12:02 PM
Announcing the 2026 HDBuzz Prize for Young Science Writers – sponsored by the Hereditary Disease Foundation! Submission details here:

en.hdbuzz.net/the-2026-hdb...
August 17, 2026 at 2:47 PM
Day 3 of #HD2026 put the huntingtin protein (HTT) under the microscope. Researchers shared new insights into HTT1a, next-generation HTT-lowering approaches, somatic expansion, brain circuitry, and why boosting healthy HTT might help. Read our roundup here:

en.hdbuzz.net/hd2026-milto...
August 14, 2026 at 3:14 PM
Day 2 #HD2026 - insights into the mechanics of somatic instability, new ways we can track Huntington’s disease (HD) in people over time, how AI can help us drive research forward, and new developments in our understanding of the HTT protein. Catch up on everything we learned on HDBuzz.net
August 13, 2026 at 4:44 PM
Welcome to Day 3 of the #HD2026 Milton Wexler Biennial Symposium, where HDBuzz is reporting live for this final day of talks. Morning sessions will focus on huntingtin (HTT), including a fragment of the expanded HTT protein that seems to be extra harmful.
August 13, 2026 at 1:06 PM
Day 1 of #HD2026 - From what human brains can teach us about HD, to HTT1a, somatic CAG expansion and the normal biology of HTT, today’s talks spanned the spectrum from fundamental biology to potential treatments. Catch up on everything we learned right here.

en.hdbuzz.net/hd-2026-milt...
August 12, 2026 at 2:53 PM
We are back for Day 2 at #HD2026! This morning kicks off with talks focussed on HD genetics and how DNA repair machines might influence how symptoms start and then progress in people with HD.
August 12, 2026 at 1:05 PM
Good morning from Boston! We’re looking forward to bringing you live updates from Day 1 of #HD2026, a biannual conference hosted by the Huntington’s Disease Foundation (HDF) that brings together HD scientists and clinicians from around the world.
August 11, 2026 at 12:46 PM
Welcome to #HD2026! Held every other year in Boston, MA and organized by the Huntington’s Disease Foundation (HDF), this conference brings together almost 300 of the world-leading experts in Huntington’s disease (HD) and other CAG repeat diseases.
August 10, 2026 at 9:58 PM
Prilenia Therapeutics has donated data from two of its Huntington’s Disease (HD) clinical trials to CHDI Foundation, creating a valuable resource that researchers can use to better understand placebo effects, disease progression and future trial design.

en.hdbuzz.net/prilenia-sha...
August 6, 2026 at 1:11 PM
Roche's decision to stop development of two huntingtin-lowering programmes is disappointing, but the story doesn't end there. Years of research have answered some key questions, raised many new ones, and will inform the next generation of HD trials. Read about it here: en.hdbuzz.net/looking-back...
August 3, 2026 at 1:01 PM
July was a hard month for Huntington’s disease research, with Roche ending two HD programs. But the month also brought promising new tools to visualize and track huntingtin, and important studies on eating and self-awareness in HD.

Read the full recap: en.hdbuzz.net/july-2026-th...
July 30, 2026 at 1:02 PM